Lazard, Inc. (0UB6.L)
| Previous close | 39.27 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 4,975 |
| Market cap | 45.767M |
| Beta (5Y monthly) | 1.46 |
| PE ratio (TTM) | 0.08 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Lazard Reports April 2024 Assets Under Management
NEW YORK, May 10, 2024--Lazard, Inc. (NYSE: LAZ) reported today that its preliminary assets under management ("AUM") as of April 30, 2024 totaled approximately $240.8 billion. The month’s AUM included market depreciation of $4.4 billion, net outflows of $3.6 billion and foreign exchange depreciation of $1.6 billion.
- Business Wire
Lazard Welcomes Michele Colocci as Vice Chairman, Investment Banking and Managing Director, Healthcare
NEW YORK, May 09, 2024--Lazard, Inc. (NYSE: LAZ) today announced Michele Colocci is joining the firm on 3rd June 2024 as Vice Chairman, Investment Banking and Managing Director, Healthcare. Based in London, Mr. Colocci’s appointment accelerates the growth of Lazard’s best-in-class global healthcare franchise, led by David Gluckman, and further reinforces its leading position in Europe, which is headed by Jean-Louis Girodolle and Cyrus Kapadia.
- Business Wire
Lazard Reports First-Quarter 2024 Results
NEW YORK, April 25, 2024--Lazard, Inc. (NYSE: LAZ) today reported net revenue of $765 million and adjusted net revenue1 of $747 million for the quarter ended March 31, 2024. On a U.S. GAAP basis, first-quarter 2024 net income was $36 million or $0.35 per share, diluted. Adjusted net income2 was $67 million, or $0.66 per share, diluted, for the quarter.
